VUGENE

📍 Kaunas, Lithuania🗓 Founded 2021👥 24 employees💰 Last funded Apr 2025
Biotechnology Research🌐 vugene.com
Website LinkedIn
At VUGENE we offer bioinformatics data science as a service. Our team is comprised of specialists in biomedical research, bioinformatics, machine learning and software engineering. Our services are tailored for research laboratories studying the origins, causes, treatments and diagnostics of various complex disorders, such as cancers or neurodegenerative disorders. Collective expertise at VUGENE enables efficient management of large datasets resulting from multi-omics experiments. We perform quality control, processing of raw experimental data, normalization, statistical analysis and training of soffisticated machine learning models. We use the latest agile software development techniques to coordinate and streamline our research processes and to write software code that leads to reproducible and publishable results.
4
Total investors
0
Early stage
4
Mid stage
0
Late stage
2021
Founded

Investors

4 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Lithuania
4
Investor activity2024–2025 · investors recorded per year
2024120253
Recent (last 2y)Earlier
Frequently asked questions
Who invested in VUGENE?
VUGENE has 4 investors on record on gritt.io, 4 mid-stage.
When did VUGENE last raise funding?
The most recent investment in VUGENE recorded on gritt.io was in April 2025.
When was VUGENE founded?
VUGENE was founded in 2021.
What industry is VUGENE in?
VUGENE operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is VUGENE based?
VUGENE is headquartered in Kaunas, Lithuania.